US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 6.530
  • -0.350-5.09%
Close Mar 28 16:00 ET
  • 6.650
  • +0.120+1.84%
Post 20:01 ET
38.26MMarket Cap-0.57P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-17.84%42.5M
-17.84%42.5M
-34.39%67.19M
-77.03%35.29M
-77.49%46.24M
-78.70%51.73M
-78.70%51.73M
-61.41%102.41M
-53.63%153.64M
-31.94%205.41M
-Cash and cash equivalents
-3.14%25.03M
-3.14%25.03M
-28.30%46.45M
-31.77%31.31M
-28.01%35.09M
-72.20%25.84M
-72.20%25.84M
-0.50%64.79M
-35.07%45.9M
-52.06%48.74M
-Short-term investments
-32.52%17.47M
-32.52%17.47M
-44.88%20.74M
-96.31%3.98M
-92.88%11.15M
-82.73%25.88M
-82.73%25.88M
-81.22%37.62M
-58.66%107.74M
-21.72%156.67M
Receivables
-95.65%1.48M
-95.65%1.48M
719.02%1.34M
377.71%2.42M
8,926.20%35.83M
-15.20%34.11M
-15.20%34.11M
-34.54%163K
-20.41%507K
-40.57%397K
-Accounts receivable
-95.65%1.48M
-95.65%1.48M
719.02%1.34M
377.71%2.42M
8,926.20%35.83M
-15.20%34.11M
-15.20%34.11M
-34.54%163K
-20.41%507K
-40.57%397K
Inventory
9.78%10.66M
9.78%10.66M
112.11%13.98M
138.51%18.75M
201.20%16.08M
511.98%9.71M
511.98%9.71M
--6.59M
--7.86M
--5.34M
Restricted cash
0.00%146K
0.00%146K
0.00%146K
0.00%146K
0.00%146K
0.00%146K
0.00%146K
-89.15%146K
-89.15%146K
0.00%146K
Other current assets
63.57%10.12M
63.57%10.12M
-1.95%9.21M
-42.93%5.8M
-36.93%8.13M
-40.01%6.18M
-40.01%6.18M
--9.39M
--10.16M
--12.89M
Total current assets
-36.30%64.89M
-36.30%64.89M
-22.61%91.86M
-63.78%62.41M
-52.52%106.43M
-65.48%101.87M
-65.48%101.87M
-58.06%118.7M
-50.34%172.32M
-28.69%224.18M
Non current assets
Net PPE
-30.09%41.1M
-30.09%41.1M
-25.56%47.49M
-24.10%51.27M
-22.57%54.97M
-20.90%58.79M
-20.90%58.79M
-18.31%63.8M
-17.54%67.54M
153.17%71M
-Gross PPE
-21.77%58.41M
-21.77%58.41M
-16.81%65.54M
-15.97%68.67M
-14.92%71.69M
-13.93%74.66M
-13.93%74.66M
-12.89%78.79M
-12.28%81.72M
120.03%84.26M
-Accumulated depreciation
-9.06%-17.31M
-9.06%-17.31M
-20.43%-18.05M
-22.75%-17.4M
-26.07%-16.72M
-27.75%-15.87M
-27.75%-15.87M
-21.37%-14.99M
-25.97%-14.18M
-29.36%-13.26M
Other non current assets
-35.94%3.1M
-35.94%3.1M
-46.62%3.36M
-45.11%3.61M
-43.99%3.87M
-30.98%4.84M
-30.98%4.84M
-12.24%6.29M
-9.02%6.58M
-87.41%6.91M
Total non current assets
-30.54%44.2M
-30.54%44.2M
-27.45%50.85M
-25.97%54.87M
-24.47%58.84M
-21.77%63.64M
-21.77%63.64M
-17.80%70.09M
-16.85%74.12M
-6.02%77.9M
Total assets
-34.08%109.1M
-34.08%109.1M
-24.41%142.71M
-52.41%117.28M
-45.29%165.27M
-56.03%165.5M
-56.03%165.5M
-48.74%188.79M
-43.49%246.44M
-23.96%302.08M
Liabilities
Current liabilities
Payables
18.54%4.37M
18.54%4.37M
-67.04%2.15M
26.95%5.25M
-43.69%2.85M
-46.38%3.68M
-46.38%3.68M
-42.36%6.51M
-67.67%4.14M
-57.57%5.07M
-accounts payable
18.54%4.37M
18.54%4.37M
-67.04%2.15M
26.95%5.25M
-43.69%2.85M
-46.38%3.68M
-46.38%3.68M
-42.36%6.51M
-67.67%4.14M
-57.57%5.07M
Current accrued expenses
-60.53%14.61M
-60.53%14.61M
-54.69%15.06M
-57.02%14.16M
47.03%34.94M
13.02%37.01M
13.02%37.01M
86.04%33.24M
117.88%32.96M
69.88%23.77M
Current debt and capital lease obligation
14.27%13.92M
14.27%13.92M
10.24%14.66M
8.07%14M
--14.03M
-10.71%12.18M
-10.71%12.18M
--13.3M
--12.95M
----
-Current capital lease obligation
14.27%13.92M
14.27%13.92M
10.24%14.66M
8.07%14M
--14.03M
-10.71%12.18M
-10.71%12.18M
--13.3M
--12.95M
----
Current deferred liabilities
22.17%95.09M
22.17%95.09M
902.02%116.34M
800.34%107.58M
1,140.97%123.15M
872.91%77.83M
872.91%77.83M
336.18%11.61M
615.08%11.95M
-80.52%9.92M
Other current liabilities
----
----
----
----
----
----
----
----
----
143.35%20.21M
Current liabilities
-5.38%134.57M
-5.38%134.57M
97.22%155.98M
98.88%148.27M
166.21%180.69M
80.22%142.23M
80.22%142.23M
9.47%79.09M
13.49%74.55M
-33.17%67.88M
Non current liabilities
Long term provisions
----
----
----
----
----
----
----
--33.25M
--32.09M
--31.11M
Long term debt and capital lease obligation
-34.53%29.91M
-34.53%29.91M
-27.35%35.24M
-25.22%38.7M
-23.16%42.2M
-21.31%45.69M
-21.31%45.69M
-20.57%48.51M
-19.13%51.75M
214.66%54.92M
-Long term capital lease obligation
-34.53%29.91M
-34.53%29.91M
-27.35%35.24M
-25.22%38.7M
-23.16%42.2M
-21.31%45.69M
-21.31%45.69M
-20.57%48.51M
-19.13%51.75M
214.66%54.92M
Non current deferred liabilities
--0
--0
-99.36%470K
-99.25%567K
-99.08%719K
-51.22%37.56M
-51.22%37.56M
74.62%73.93M
74.40%75.57M
73.42%78.04M
Other non current liabilities
6.72%41.89M
6.72%41.89M
757.12%41.55M
708.58%40.62M
672.15%39.97M
9.65%39.25M
9.65%39.25M
-12.63%4.85M
-10.72%5.02M
740.42%5.18M
Total non current liabilities
-41.39%71.81M
-41.39%71.81M
-51.87%77.27M
-51.42%79.89M
-51.02%82.89M
-28.30%122.51M
-28.30%122.51M
47.34%160.54M
45.58%164.43M
137.03%169.25M
Total liabilities
-22.04%206.38M
-22.04%206.38M
-2.66%233.25M
-4.53%228.15M
11.16%263.58M
5.99%264.74M
5.99%264.74M
32.24%239.63M
33.78%238.99M
37.09%237.12M
Shareholders'equity
Share capital
--1K
--1K
-90.00%1K
--0
20.00%12K
--0
--0
11.11%10K
11.11%10K
11.11%10K
-common stock
--1K
--1K
-90.00%1K
--0
20.00%12K
--0
--0
11.11%10K
11.11%10K
11.11%10K
Retained earnings
-4.34%-2.05B
-4.34%-2.05B
-6.98%-2.04B
-9.85%-2.02B
-13.19%-2B
-16.31%-1.97B
-16.31%-1.97B
-17.93%-1.91B
-19.85%-1.84B
-13.84%-1.77B
Paid-in capital
4.66%1.96B
4.66%1.96B
5.00%1.95B
3.35%1.91B
3.74%1.9B
2.66%1.87B
2.66%1.87B
2.76%1.86B
2.94%1.85B
3.09%1.83B
Gains losses not affecting retained earnings
103.92%8K
103.92%8K
103.85%22K
98.50%-14K
95.55%-55K
90.13%-204K
90.13%-204K
80.70%-571K
64.36%-933K
34.62%-1.24M
Total stockholders'equity
1.96%-97.28M
1.96%-97.28M
-78.09%-90.54M
-1,587.36%-110.87M
-251.34%-98.31M
-178.36%-99.23M
-178.36%-99.23M
-127.17%-50.84M
-97.11%7.45M
-71.04%64.96M
Total equity
1.96%-97.28M
1.96%-97.28M
-78.09%-90.54M
-1,587.36%-110.87M
-251.34%-98.31M
-178.36%-99.23M
-178.36%-99.23M
-127.17%-50.84M
-97.11%7.45M
-71.04%64.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -17.84%42.5M-17.84%42.5M-34.39%67.19M-77.03%35.29M-77.49%46.24M-78.70%51.73M-78.70%51.73M-61.41%102.41M-53.63%153.64M-31.94%205.41M
-Cash and cash equivalents -3.14%25.03M-3.14%25.03M-28.30%46.45M-31.77%31.31M-28.01%35.09M-72.20%25.84M-72.20%25.84M-0.50%64.79M-35.07%45.9M-52.06%48.74M
-Short-term investments -32.52%17.47M-32.52%17.47M-44.88%20.74M-96.31%3.98M-92.88%11.15M-82.73%25.88M-82.73%25.88M-81.22%37.62M-58.66%107.74M-21.72%156.67M
Receivables -95.65%1.48M-95.65%1.48M719.02%1.34M377.71%2.42M8,926.20%35.83M-15.20%34.11M-15.20%34.11M-34.54%163K-20.41%507K-40.57%397K
-Accounts receivable -95.65%1.48M-95.65%1.48M719.02%1.34M377.71%2.42M8,926.20%35.83M-15.20%34.11M-15.20%34.11M-34.54%163K-20.41%507K-40.57%397K
Inventory 9.78%10.66M9.78%10.66M112.11%13.98M138.51%18.75M201.20%16.08M511.98%9.71M511.98%9.71M--6.59M--7.86M--5.34M
Restricted cash 0.00%146K0.00%146K0.00%146K0.00%146K0.00%146K0.00%146K0.00%146K-89.15%146K-89.15%146K0.00%146K
Other current assets 63.57%10.12M63.57%10.12M-1.95%9.21M-42.93%5.8M-36.93%8.13M-40.01%6.18M-40.01%6.18M--9.39M--10.16M--12.89M
Total current assets -36.30%64.89M-36.30%64.89M-22.61%91.86M-63.78%62.41M-52.52%106.43M-65.48%101.87M-65.48%101.87M-58.06%118.7M-50.34%172.32M-28.69%224.18M
Non current assets
Net PPE -30.09%41.1M-30.09%41.1M-25.56%47.49M-24.10%51.27M-22.57%54.97M-20.90%58.79M-20.90%58.79M-18.31%63.8M-17.54%67.54M153.17%71M
-Gross PPE -21.77%58.41M-21.77%58.41M-16.81%65.54M-15.97%68.67M-14.92%71.69M-13.93%74.66M-13.93%74.66M-12.89%78.79M-12.28%81.72M120.03%84.26M
-Accumulated depreciation -9.06%-17.31M-9.06%-17.31M-20.43%-18.05M-22.75%-17.4M-26.07%-16.72M-27.75%-15.87M-27.75%-15.87M-21.37%-14.99M-25.97%-14.18M-29.36%-13.26M
Other non current assets -35.94%3.1M-35.94%3.1M-46.62%3.36M-45.11%3.61M-43.99%3.87M-30.98%4.84M-30.98%4.84M-12.24%6.29M-9.02%6.58M-87.41%6.91M
Total non current assets -30.54%44.2M-30.54%44.2M-27.45%50.85M-25.97%54.87M-24.47%58.84M-21.77%63.64M-21.77%63.64M-17.80%70.09M-16.85%74.12M-6.02%77.9M
Total assets -34.08%109.1M-34.08%109.1M-24.41%142.71M-52.41%117.28M-45.29%165.27M-56.03%165.5M-56.03%165.5M-48.74%188.79M-43.49%246.44M-23.96%302.08M
Liabilities
Current liabilities
Payables 18.54%4.37M18.54%4.37M-67.04%2.15M26.95%5.25M-43.69%2.85M-46.38%3.68M-46.38%3.68M-42.36%6.51M-67.67%4.14M-57.57%5.07M
-accounts payable 18.54%4.37M18.54%4.37M-67.04%2.15M26.95%5.25M-43.69%2.85M-46.38%3.68M-46.38%3.68M-42.36%6.51M-67.67%4.14M-57.57%5.07M
Current accrued expenses -60.53%14.61M-60.53%14.61M-54.69%15.06M-57.02%14.16M47.03%34.94M13.02%37.01M13.02%37.01M86.04%33.24M117.88%32.96M69.88%23.77M
Current debt and capital lease obligation 14.27%13.92M14.27%13.92M10.24%14.66M8.07%14M--14.03M-10.71%12.18M-10.71%12.18M--13.3M--12.95M----
-Current capital lease obligation 14.27%13.92M14.27%13.92M10.24%14.66M8.07%14M--14.03M-10.71%12.18M-10.71%12.18M--13.3M--12.95M----
Current deferred liabilities 22.17%95.09M22.17%95.09M902.02%116.34M800.34%107.58M1,140.97%123.15M872.91%77.83M872.91%77.83M336.18%11.61M615.08%11.95M-80.52%9.92M
Other current liabilities ------------------------------------143.35%20.21M
Current liabilities -5.38%134.57M-5.38%134.57M97.22%155.98M98.88%148.27M166.21%180.69M80.22%142.23M80.22%142.23M9.47%79.09M13.49%74.55M-33.17%67.88M
Non current liabilities
Long term provisions ------------------------------33.25M--32.09M--31.11M
Long term debt and capital lease obligation -34.53%29.91M-34.53%29.91M-27.35%35.24M-25.22%38.7M-23.16%42.2M-21.31%45.69M-21.31%45.69M-20.57%48.51M-19.13%51.75M214.66%54.92M
-Long term capital lease obligation -34.53%29.91M-34.53%29.91M-27.35%35.24M-25.22%38.7M-23.16%42.2M-21.31%45.69M-21.31%45.69M-20.57%48.51M-19.13%51.75M214.66%54.92M
Non current deferred liabilities --0--0-99.36%470K-99.25%567K-99.08%719K-51.22%37.56M-51.22%37.56M74.62%73.93M74.40%75.57M73.42%78.04M
Other non current liabilities 6.72%41.89M6.72%41.89M757.12%41.55M708.58%40.62M672.15%39.97M9.65%39.25M9.65%39.25M-12.63%4.85M-10.72%5.02M740.42%5.18M
Total non current liabilities -41.39%71.81M-41.39%71.81M-51.87%77.27M-51.42%79.89M-51.02%82.89M-28.30%122.51M-28.30%122.51M47.34%160.54M45.58%164.43M137.03%169.25M
Total liabilities -22.04%206.38M-22.04%206.38M-2.66%233.25M-4.53%228.15M11.16%263.58M5.99%264.74M5.99%264.74M32.24%239.63M33.78%238.99M37.09%237.12M
Shareholders'equity
Share capital --1K--1K-90.00%1K--020.00%12K--0--011.11%10K11.11%10K11.11%10K
-common stock --1K--1K-90.00%1K--020.00%12K--0--011.11%10K11.11%10K11.11%10K
Retained earnings -4.34%-2.05B-4.34%-2.05B-6.98%-2.04B-9.85%-2.02B-13.19%-2B-16.31%-1.97B-16.31%-1.97B-17.93%-1.91B-19.85%-1.84B-13.84%-1.77B
Paid-in capital 4.66%1.96B4.66%1.96B5.00%1.95B3.35%1.91B3.74%1.9B2.66%1.87B2.66%1.87B2.76%1.86B2.94%1.85B3.09%1.83B
Gains losses not affecting retained earnings 103.92%8K103.92%8K103.85%22K98.50%-14K95.55%-55K90.13%-204K90.13%-204K80.70%-571K64.36%-933K34.62%-1.24M
Total stockholders'equity 1.96%-97.28M1.96%-97.28M-78.09%-90.54M-1,587.36%-110.87M-251.34%-98.31M-178.36%-99.23M-178.36%-99.23M-127.17%-50.84M-97.11%7.45M-71.04%64.96M
Total equity 1.96%-97.28M1.96%-97.28M-78.09%-90.54M-1,587.36%-110.87M-251.34%-98.31M-178.36%-99.23M-178.36%-99.23M-127.17%-50.84M-97.11%7.45M-71.04%64.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%
KB Home
KBH
-2.50%

Unlock the Full List